Datasets:
jarrydmartinx
/
support2

Dataset card Data Studio Files
xet
Community
age
float64
18
102
sex
stringclasses
2 values
hospdead
int64
0
1
slos
int64
3
343
dzgroup
stringclasses
8 values
dzclass
stringclasses
4 values
num.co
int64
0
9
edu
float64
0
31
⌀
income
stringclasses
4 values
scoma
float64
0
100
⌀
charges
float64
1.17k
1.44M
⌀
totcst
float64
0
633k
⌀
totmcst
float64
-102.72
711k
⌀
avtisst
float64
1
83
⌀
race
stringclasses
5 values
sps
float64
0.2
99.2
⌀
aps
float64
0
143
⌀
surv2m
float64
0
0.97
⌀
surv6m
float64
0
0.95
⌀
hday
int64
1
148
diabetes
int64
0
1
dementia
int64
0
1
ca
stringclasses
3 values
prg2m
float64
0
1
⌀
prg6m
float64
0
1
⌀
dnr
stringclasses
3 values
dnrday
float64
-88
285
⌀
meanbp
float64
0
195
⌀
wblc
float64
0
200
⌀
hrt
float64
0
300
⌀
resp
float64
0
90
⌀
temp
float64
31.7
41.7
⌀
pafi
float64
12
890
⌀
alb
float64
0.4
29
⌀
bili
float64
0.1
63
⌀
crea
float64
0.1
21.5
⌀
sod
float64
110
181
⌀
ph
float64
6.83
7.77
⌀
glucose
float64
0
1.09k
⌀
bun
float64
1
300
⌀
urine
float64
0
9k
⌀
adlp
float64
0
7
⌀
adls
float64
0
7
⌀
sfdm2
stringclasses
5 values
adlsc
float64
0
7.07
event_times
int64
3
2.03k
event_indicators
int64
0
1
73.59296
male
1
25
ARF/MOSF w/Sepsis
ARF/MOSF
3
6
under $11k
44
72,719
45,524.3125
52,509.4688
29.5
black
29.796875
48
0.380981
0.261963
1
0
0
yes
0.25
0.4
no dnr
25
53
21.796875
67
28
35.5
null
2.199707
0.199982
0.699951
131
null
80
12
750
null
0
<2 mo. follow-up
0
25
1
77.73596
female
1
18
MOSF w/Malig
ARF/MOSF
1
null
under $11k
44
29,169
19,525.7812
25,135.4844
25.333328
black
22.699219
24
0.434998
0.315979
7
0
0
yes
0
0
dnr before sadm
-1
83
null
76
18
36.5
null
null
null
1.199951
135
null
86
6
5,050
null
5
<2 mo. follow-up
5
18
1
49.56897
male
1
27
Cirrhosis
COPD/CHF/Cirrhosis
1
null
under $11k
0
50,888
32,832.5938
40,125.4688
35.75
white
34.796875
54
0.565918
0.369995
1
0
0
no
0.75
0.3
dnr after sadm
21
74
9.099609
101
24
35.79688
null
4.5
1.799805
2
137
null
100
46
null
null
1
<2 mo. follow-up
1
27
1
62.05298
male
0
41
ARF/MOSF w/Sepsis
ARF/MOSF
2
12
$11-$25k
0
104,496
66,482.625
75,413.8125
52.25
white
27.5
69
0.764893
0.688965
1
0
0
no
0.5
0.5
no dnr
41
103
10.699219
68
14
36
247.59375
3.599609
0.799927
1.799805
138
7.40918
122
35
4,050
null
0
no(M2 and SIP pres)
0
1,039
0
63.51498
male
0
23
ARF/MOSF w/Sepsis
ARF/MOSF
0
16
$25-$50k
9
85,938
57,368.0938
62,982.0312
13.666664
white
22.796875
37
0.740967
0.659912
18
0
0
no
1
1
no dnr
23
70
3.339844
150
22
36.5
303.3125
2.699707
0.699951
2.5
133
7.419922
205
39
2,520
0
0
no(M2 and SIP pres)
0
914
1
76.73096
male
0
11
COPD
COPD/CHF/Cirrhosis
1
12
$11-$25k
0
11,799
7,380.9805
9,713.4375
11
white
16.199219
19
0.851929
0.756958
1
0
0
no
1
0.9
no dnr
11
114
5.5
119
41
40.29688
296.625
2.599609
1.5
1.899902
147
7.399414
216
27
4,517
0
0
no(M2 and SIP pres)
0
157
1
76.62695
female
1
26
ARF/MOSF w/Sepsis
ARF/MOSF
2
12
under $11k
0
89,138
56,273.4062
65,897.5625
33.25
white
26.296875
42
0.67395
0.578979
5
0
0
no
0.6
0.6
dnr after sadm
23
55
36.59375
190
24
36.39844
455.5
1.399902
0.899902
6.299805
125
7.40918
89
68
1,100
null
5
<2 mo. follow-up
5
26
1
75.53699
male
0
43
ARF/MOSF w/Sepsis
ARF/MOSF
0
10
under $11k
9
98,295
64,238.125
78,530.8125
42.75
white
34.398438
63
0.471985
0.353943
2
0
0
no
0.75
0.75
dnr after sadm
28
100
6.899414
110
24
36.89844
null
3.799805
0.299988
1
139
null
125
10
2,520
null
0
adl>=4 (>=5 if sur)
0
1,038
0
36.73898
female
0
11
CHF
COPD/CHF/Cirrhosis
1
14
null
0
28,019
17,699.375
20,122.5625
23.5
black
24.597656
37
0.85791
0.764893
10
0
0
no
0.75
0.75
no dnr
11
47
0.799927
124
36
35.79688
177.75
2.5
0.699951
2.099609
136
7.40918
99
54
1,280
0
0
no(M2 and SIP pres)
0
1,036
0
66.71594
male
0
21
CHF
COPD/CHF/Cirrhosis
1
12
$11-$25k
0
52,966
32,957.3125
38,379.125
29
white
19.597656
22
0.860962
0.769897
1
0
0
no
0.95
0.9
no dnr
21
130
20.199219
156
40
36.09375
220.40625
2.099609
5.099609
1.299805
127
7.389648
57
26
1,525
4
1
no(M2 and SIP pres)
1
1,037
0
48.91699
female
0
6
ARF/MOSF w/Sepsis
ARF/MOSF
0
13
$11-$25k
0
11,941
7,673.4336
8,605.97656
36
white
18.097656
23
0.907959
0.873901
1
0
0
no
0.9
0.95
no dnr
6
79
9.298828
118
24
36
404.75
3.699707
0.599976
2.199707
132
7.489258
110
55
1,645
1
null
no(M2 and SIP pres)
1.166748
1,037
0
80.73895
female
0
18
COPD
COPD/CHF/Cirrhosis
1
8
under $11k
0
26,876
16,527.1719
20,001.3438
20.666656
white
21.597656
21
0.751953
0.60791
1
0
0
no
0.75
0.75
dnr after sadm
14
81
0.049995
104
22
40
null
2.5
1.799805
1
132
null
254
13
4,725
0
0
no(M2 and SIP pres)
0
1,036
0
71.01996
female
1
3
MOSF w/Malig
ARF/MOSF
1
12
null
100
9,989
6,770.5664
8,636.40625
null
white
45.398438
70
0
0
7
0
0
metastatic
null
null
dnr before sadm
-1
70
13.199219
126
24
39.39844
null
2.5
0.5
0.899902
132
null
90
8
null
null
null
<2 mo. follow-up
4.333008
3
1
30.765
male
0
6
MOSF w/Malig
ARF/MOSF
0
null
null
0
19,435
13,216.4766
20,892.7656
6
white
23.898438
31
0.685913
0.593994
7
0
0
yes
0.98
0.9
no dnr
6
83
10.599609
135
20
35.89844
476
3.899902
0.399963
1.299805
139
7.399414
404
22
3,800
null
null
null
2.511231
832
1
41.95999
female
1
5
ARF/MOSF w/Sepsis
ARF/MOSF
3
12
null
0
27,633
0
0
63
white
43.195313
100
0.492981
0.375977
2
0
0
no
0.01
0.000001
dnr after sadm
5
76
7.899414
124
24
36.39844
167.34375
2.399902
6
3
133
7.359375
173
70
638
null
0
<2 mo. follow-up
0
5
1
79.258
male
0
10
Lung Cancer
Cancer
1
12
under $11k
26
8,220
6,202.9141
7,946.50781
10
black
16.5
16
0.575928
0.254944
1
0
0
metastatic
0.2
0
dnr after sadm
1
107
19.097656
107
24
36.59375
165.28125
2.299805
2
7.399414
135
7.319336
242
80
790
null
5
<2 mo. follow-up
5
37
1
79.159
male
1
15
ARF/MOSF w/Sepsis
ARF/MOSF
5
15
under $11k
61
16,072
10,463.8125
12,797.9375
27.333328
black
36.296875
69
0.159973
0.078995
1
1
1
no
0.5
0.1
dnr after sadm
3
75
5.299805
104
40
38.29688
283.3125
2.5
1
0.799927
143
7.399414
97
7
4,550
null
7
<2 mo. follow-up
7
15
1
70.38495
male
1
4
Lung Cancer
Cancer
3
10
under $11k
9
4,010
2,658.7598
3,309.26953
22
white
41.59375
37
0.046997
0.001
1
1
0
metastatic
0.1
0
dnr after sadm
2
74
41.398438
107
8
37.79688
247.5
2.299805
5.5
4.5
146
7.359375
233
147
1,955
null
null
<2 mo. follow-up
3.628906
4
1
91.86597
female
1
6
Coma
Coma
0
6
under $11k
89
9,946
6,350.8555
7,375.4375
36
white
36.695313
69
0
0
1
0
0
no
0
0
dnr after sadm
3
67
6.5
93
20
37.5
null
2.199707
1.199951
3.599609
140
null
75
49
null
null
1
<2 mo. follow-up
1
6
1
71.81396
female
0
20
ARF/MOSF w/Sepsis
ARF/MOSF
4
10
$11-$25k
0
34,771
19,316.3281
22,610.3281
35.333313
white
25.898438
55
0.751953
0.672974
1
1
0
no
0.8
0.6
no dnr
20
69
7.199219
107
24
37.79688
null
null
0.399963
0.799927
140
null
146
13
425
null
6
adl>=4 (>=5 if sur)
6
845
1
66.09998
female
1
34
Cirrhosis
COPD/CHF/Cirrhosis
4
10
under $11k
0
118,170
75,117.25
92,485.625
52.75
white
34.195313
84
0.409973
0.210999
1
1
0
no
0.25
0.15
dnr after sadm
34
62
3.699707
106
27
38
null
2.599609
38.898438
1.199951
126
null
86
29
1,465
null
0
<2 mo. follow-up
0
34
1
42.31598
male
0
10
ARF/MOSF w/Sepsis
ARF/MOSF
0
0
under $11k
26
16,046
10,801.6797
12,408.9688
34
white
19.5
14
0.870972
0.824951
1
0
0
no
0.9
0.9
no dnr
10
119
10.298828
114
32
36.19531
232.625
4.099609
0.199982
1.099854
138
7.419922
182
19
2,020
null
0
adl>=4 (>=5 if sur)
0
1,030
0
45.05698
male
0
26
ARF/MOSF w/Sepsis
ARF/MOSF
0
10
under $11k
9
48,690
32,809.0625
37,353.625
14.75
white
21.699219
34
0.844971
0.791992
5
0
0
no
0.95
0.95
no dnr
26
99
25.699219
107
24
36.39844
228.5625
2.599609
1.199951
0.699951
135
7.399414
84
15
1,200
0
0
no(M2 and SIP pres)
0
1,027
0
73.49194
male
0
6
CHF
COPD/CHF/Cirrhosis
3
12
under $11k
0
6,658
3,897.0918
5,010.66797
7
white
16.398438
35
0.873901
0.790894
1
0
0
no
0.8
0.7
no dnr
6
71
18.898438
126
24
39
268
2.799805
1
1.099854
131
7.579102
107
13
4,010
5
4
no(M2 and SIP pres)
4
1,027
0
63.23599
male
1
33
ARF/MOSF w/Sepsis
ARF/MOSF
3
8
under $11k
0
101,217
64,560.5625
77,224.375
53.75
white
27.398438
60
0.690918
0.598999
12
0
0
no
0.6
0.6
dnr after sadm
33
100
11.699219
82
20
36.19531
224
3.699707
1
0.899902
138
7.369141
175
17
1,550
null
2
<2 mo. follow-up
2
33
1
38.59799
male
0
7
Cirrhosis
COPD/CHF/Cirrhosis
2
11
under $11k
0
8,412
5,658.4922
5,928.22656
6.5
white
20
26
0.883911
0.806885
1
0
0
no
0.65
0.5
no dnr
7
102
10.599609
77
30
38.29688
null
3.099609
1.599854
1.099854
139
null
86
19
3,100
null
null
no(M2 and SIP pres)
3.171387
187
1
66.05597
male
0
12
MOSF w/Malig
ARF/MOSF
1
10
$11-$25k
26
11,636
8,340.9766
10,750.9297
12.5
white
28
50
0.396973
0.277954
1
0
0
metastatic
0.7
0.6
dnr after sadm
1
83
7.599609
123
28
38.39844
265.6875
1.699951
1.099854
2.5
135
7.429688
132
51
2,523
null
6
<2 mo. follow-up
6
32
1
68.59399
male
0
20
Cirrhosis
COPD/CHF/Cirrhosis
4
7
under $11k
0
24,108
16,869.2656
20,222.0781
13.333328
black
18.898438
19
0.756958
0.615967
1
0
0
no
0.95
0.9
no dnr
20
123
9.699219
70
20
35.79688
null
null
null
2.099609
133
7.449219
116
41
1,750
0
1
null
1
758
1
78.05298
male
0
7
COPD
COPD/CHF/Cirrhosis
4
null
null
9
6,979
4,518.457
5,866.95703
7
white
17.296875
45
0.810913
0.69397
1
0
0
no
1
0.9
no dnr
7
111
9.398438
120
10
36
217.5
1.699951
3.799805
3.799805
138
7.359375
80
55
435
7
5
adl>=4 (>=5 if sur)
5
1,025
0
67.86896
male
0
16
Lung Cancer
Cancer
4
10
under $11k
0
14,776
10,952.4766
13,473.75
13
black
23.199219
23
0.555908
0.233978
1
1
0
metastatic
0.9
0.75
no dnr
16
77
7.899414
110
24
36.19531
null
3
1.5
0.899902
131
null
220
11
1,350
5
null
no(M2 and SIP pres)
3.854981
87
1
65.24298
male
0
9
Lung Cancer
Cancer
6
12
$11-$25k
0
12,269
8,320.5469
9,107.85938
7.5
white
17.699219
28
0.69397
0.403992
1
0
0
metastatic
0.1
0.02
dnr after sadm
5
103
4.799805
65
22
37.29688
null
2.899902
0.5
3.699707
132
null
101
50
4,700
3
1
<2 mo. follow-up
1
31
1
94.70996
male
1
4
ARF/MOSF w/Sepsis
ARF/MOSF
0
4
under $11k
41
8,346
4,438.5547
5,558.12891
29
black
27.699219
41
0.396973
0.277954
1
0
0
no
null
null
no dnr
4
61
17.296875
115
14
38.69531
180
2
11.898438
2.299805
157
7.459961
368
72
2,645
null
5
<2 mo. follow-up
5
4
1
45.57999
female
1
9
ARF/MOSF w/Sepsis
ARF/MOSF
0
14
>$50k
0
30,749
19,384.8438
23,149.7812
70
white
31.597656
40
0.760986
0.684937
1
0
0
no
0.95
0.95
dnr after sadm
9
121
22.699219
136
27
39
232.5
3.199707
0.599976
1.099854
136
7.469727
128
10
2,600
null
0
<2 mo. follow-up
0
9
1
63.16199
female
1
12
ARF/MOSF w/Sepsis
ARF/MOSF
2
13
under $11k
55
65,833
42,372.0938
52,720.125
50
white
37.898438
65
0.161987
0.080994
8
0
0
no
0.8
0.7
dnr after sadm
10
118
8.099609
64
12
38.69531
187.5
2
8
0.799927
136
7.419922
79
12
4,825
null
0
<2 mo. follow-up
0
12
1
66.08899
female
0
45
MOSF w/Malig
ARF/MOSF
1
11
$11-$25k
0
73,540
50,863.8125
54,533.7188
35
white
26.699219
37
0.496948
0.379944
5
0
0
metastatic
0.9
0.8
no dnr
45
79
8.298828
110
24
35.79688
204.75
3.599609
1.299805
0.599976
139
7.419922
262
8
null
0
0
SIP>=30
0
154
1
65.86395
male
1
8
ARF/MOSF w/Sepsis
ARF/MOSF
3
null
$11-$25k
41
20,931
10,538.9219
13,591.3672
38
white
38.59375
51
0.21698
0.119995
4
0
0
no
0.5
0.25
no dnr
8
139
17.296875
124
38
36
182.84375
4.099609
0.799927
0.899902
142
7.509766
151
19
null
null
0
<2 mo. follow-up
0
8
1
51.96198
male
0
5
Colon Cancer
Cancer
1
13
$25-$50k
0
13,199
8,313.1406
9,304.17969
17
white
12.798828
10
0.882935
0.734985
1
0
0
metastatic
0.85
0.85
no dnr
5
72
5.899414
65
28
35.39844
null
3.399902
1
1.399902
137
7.5
95
29
600
0
0
no(M2 and SIP pres)
0
1,019
0
78.71295
female
0
14
Lung Cancer
Cancer
4
null
under $11k
0
10,003
7,692.2266
10,223.0234
7
white
15.199219
34
0.710938
0.429993
1
0
0
metastatic
0.5
0.1
dnr before sadm
-1
72
13.798828
110
32
38.09375
304
null
0.199982
7
173
7.339844
98
148
525
0
null
null
0.494751
61
1
77.87
female
0
34
ARF/MOSF w/Sepsis
ARF/MOSF
1
0
under $11k
0
59,632
37,024.9688
45,438.25
33.25
black
34.195313
52
0.487976
0.369995
3
0
0
no
0.05
0.000125
no dnr
34
72
22.5
167
12
37.09375
336.625
1.899902
5.099609
1.399902
118
7.489258
219
57
842
null
0
adl>=4 (>=5 if sur)
0
232
1
56.86499
male
1
13
Coma
Coma
2
16
$25-$50k
100
30,854
16,650.0625
20,634.2188
28.5
black
25
67
0.199982
0.139984
4
1
0
no
0.05
0.03
dnr after sadm
11
61
6.799805
94
8
36.5
336.625
2.399902
0.5
0.799927
137
7.469727
160
15
1,855
null
1
<2 mo. follow-up
1
13
1
23.68799
male
0
7
ARF/MOSF w/Sepsis
ARF/MOSF
0
null
under $11k
9
32,150
21,773.7969
24,667.1562
5.5
black
27
24
0.831909
0.774902
9
0
0
no
null
null
no dnr
7
68
11.099609
103
36
36.19531
293.3125
2.299805
3.699707
1.299805
136
7.429688
277
23
2,470
null
null
null
2.947266
1,018
0
48.98798
female
0
21
MOSF w/Malig
ARF/MOSF
2
11
$25-$50k
0
41,310
27,047.2812
32,100.8281
37.666657
white
31.796875
48
0.425964
0.306946
2
0
0
metastatic
0.5
0.5
no dnr
21
123
23
136
26
36.39844
310
2.699707
1
3.299805
142
7.459961
230
54
1,546
null
2
no(M2 and SIP pres)
2
501
1
19.70999
male
0
26
ARF/MOSF w/Sepsis
ARF/MOSF
0
null
under $11k
0
62,643
40,415.6875
47,093.0938
25.5
black
27.699219
38
0.866943
0.819946
4
0
0
no
0.5
0.4
no dnr
26
57
5
129
12
39.39844
108.32812
2.5
2.299805
0.799927
131
7.459961
91
6
3,275
null
7
null
7
303
1
62.75198
female
0
38
Coma
Coma
0
12
null
61
75,458
48,957.2188
56,833.6875
30
white
17.199219
25
0.613892
0.550903
1
0
0
no
0.8
0.8
no dnr
38
50
7.099609
50
10
34.09375
380.9375
2.5
0.5
1.5
150
7.399414
47
33
2,535
null
0
no(M2 and SIP pres)
0
1,016
0
56.71698
male
0
52
Coma
Coma
1
null
null
100
71,283
46,700.2812
54,950.3125
30.5
white
24.597656
38
0.269958
0.201996
1
0
0
no
0.2
0.1
dnr after sadm
28
96
1.199951
69
20
36.29688
null
3.299805
0.299988
0.899902
142
null
170
10
2,750
null
null
null
3.061035
437
1
59.79498
female
0
6
COPD
COPD/CHF/Cirrhosis
4
10
under $11k
0
5,397
3,738.9668
4,557.79688
12
white
12.298828
20
0.920898
0.865967
1
0
0
yes
0.95
0.95
no dnr
6
71
0.299988
114
20
36.89844
null
3.799805
1
1.699951
133
null
188
21
2,575
1
4
no(M2 and SIP pres)
4
1,012
0
85.284
female
0
11
ARF/MOSF w/Sepsis
ARF/MOSF
3
12
under $11k
9
16,843
10,260.3906
11,922.4453
21
white
30.097656
47
0.469971
0.35199
1
0
0
yes
0.9
0.75
dnr after sadm
8
73
40.695313
77
38
35.69531
104
2
0.599976
2.699707
141
7.5
152
59
319
2
1
<2 mo. follow-up
1
42
1
77.85596
female
1
7
CHF
COPD/CHF/Cirrhosis
2
7
under $11k
0
6,140
4,446.1875
5,399.77734
23
black
15.298828
19
0.802979
0.681885
1
0
0
metastatic
0.7
0.6
dnr after sadm
7
64
12.298828
120
37
39.09375
160
2.5
0.699951
1.599854
132
7.429688
114
22
1,810
0
0
<2 mo. follow-up
0
7
1
67.08295
male
0
48
ARF/MOSF w/Sepsis
ARF/MOSF
1
8
under $11k
0
88,688
58,003.0625
67,012
38.75
white
15.099609
23
0.897949
0.860962
1
1
0
no
0.75
0.75
no dnr
48
117
9.398438
77
36
36.39844
null
null
null
0.799927
126
null
112
16
1,850
0
1
no(M2 and SIP pres)
1
1,009
0
67.836
male
0
16
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
under $11k
9
31,353
21,080.125
24,101.3438
22.666656
white
26.097656
38
0.696899
0.605957
4
0
0
no
0.95
0.9
no dnr
16
74
17.296875
65
36
37.69531
108.32812
2.399902
9.699219
1.299805
129
7.469727
74
32
2,419
0
0
SIP>=30
0
1,008
0
78.05597
female
0
45
ARF/MOSF w/Sepsis
ARF/MOSF
2
5
under $11k
0
100,750
63,637.6562
76,393.9375
36.75
black
25.597656
36
0.730957
0.647949
1
0
0
no
0.5
0.4
no dnr
45
69
9.5
189
10
38.5
146
1.399902
2
1.799805
147
7.599609
208
37
2,517
null
4
adl>=4 (>=5 if sur)
4
195
1
71.95599
female
0
13
CHF
COPD/CHF/Cirrhosis
3
11
under $11k
0
9,569
7,085.5625
7,397.41797
9
white
26.296875
36
0.691895
0.525879
1
1
0
yes
0.9
0.8
no dnr
13
113
12.599609
63
36
35.89844
286.625
2.399902
2.599609
1.299805
136
7.40918
152
29
2,150
1
0
no(M2 and SIP pres)
0
1,008
0
65.88599
female
1
18
MOSF w/Malig
ARF/MOSF
1
9
under $11k
9
null
null
null
35.333313
black
34.195313
70
0.272949
0.164978
2
0
0
metastatic
0.3
0.1
null
null
77
14
104
20
36.09375
203.3125
4.199219
0.399963
1.099854
142
7.449219
145
21
3,090
1
0
<2 mo. follow-up
0
18
1
57.13898
female
1
35
ARF/MOSF w/Sepsis
ARF/MOSF
3
12
under $11k
0
124,947
80,193.3125
92,762.125
49.25
white
27.597656
73
0.733887
0.650879
6
1
0
no
0.5
0.5
no dnr
35
120
16
48
10
35.29688
188
1.899902
0.699951
0.699951
134
7.509766
138
17
2,713
null
6
<2 mo. follow-up
6
35
1
67.68195
female
1
9
ARF/MOSF w/Sepsis
ARF/MOSF
2
null
under $11k
9
54,893
33,656.0312
39,587.3438
48
black
35.296875
79
0.44696
0.327942
6
1
0
no
0.5
0.5
dnr after sadm
8
53
17
120
26
38.79688
230
2.599609
5.399414
1.599854
155
7.449219
143
46
2,690
null
0
<2 mo. follow-up
0
9
1
63.814
male
0
6
ARF/MOSF w/Sepsis
ARF/MOSF
3
12
$25-$50k
9
19,911
12,975.0781
15,298.0156
34
white
24.699219
39
0.741943
0.660889
4
1
0
no
0.95
0.9
no dnr
6
134
8.298828
129
8
38
193.3125
2.799805
1.699951
0.899902
147
7.5
62
11
7,220
1
0
null
0
92
1
87.29095
female
0
11
ARF/MOSF w/Sepsis
ARF/MOSF
1
null
under $11k
41
19,740
12,731.9453
14,307.5
21.5
white
23.199219
35
0.574951
0.463989
1
0
1
no
0.4
0.35
dnr after sadm
4
74
10.599609
116
16
36.19531
428
3.799805
1
1.399902
141
7.479492
74
23
4,760
null
4
<2 mo. follow-up
4
23
1
67.29895
male
0
54
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
$11-$25k
37
173,938
115,405.938
130,774.312
46
white
29.199219
48
0.43396
0.314941
29
0
0
no
0.85
0.75
no dnr
54
130
10.898438
71
32
38
202.5
3
0.699951
1.399902
143
7.469727
162
10
1,305
null
2
no(M2 and SIP pres)
2
706
1
53.88898
female
0
28
Coma
Coma
2
12
under $11k
94
46,212
31,023.3125
34,375.7812
26.75
white
24
53
0.179993
0.122986
1
1
0
metastatic
0.1
0.05
dnr after sadm
8
116
10.5
72
8
36.59375
195
2.699707
1.199951
1.299805
139
7.389648
137
22
1,760
null
6
SIP>=30
6
1,002
0
51.43298
female
0
6
ARF/MOSF w/Sepsis
ARF/MOSF
0
12
under $11k
0
8,304
4,943.8906
5,949.29688
21
black
21.597656
22
0.872925
0.828979
1
0
0
no
1
1
no dnr
6
31
18.597656
63
36
36.29688
122.5
2.199707
2
0.899902
138
7.459961
107
20
2,030
0
0
no(M2 and SIP pres)
0
1,002
0
74.47498
male
0
3
Lung Cancer
Cancer
1
12
$11-$25k
0
2,994
2,017.0703
2,427.87891
null
white
19.5
20
0.629883
0.317993
1
0
0
metastatic
0.8
0.6
no dnr
3
69
42.59375
101
24
37.89844
null
4.099609
1.399902
1.5
128
null
99
30
2,200
0
0
no(M2 and SIP pres)
0
265
1
51.41699
female
0
10
ARF/MOSF w/Sepsis
ARF/MOSF
0
10
null
0
15,681
10,553.5234
12,059.9141
19.5
black
21.699219
42
0.871948
0.827881
1
0
0
no
0.95
0.85
no dnr
10
56
17
129
24
38.19531
72
2.5
5.5
5
146
7.289062
37
40
207
0
0
no(M2 and SIP pres)
0
1,000
0
63.258
male
0
5
COPD
COPD/CHF/Cirrhosis
5
11
under $11k
0
8,534
4,432.4023
5,277.58984
19
white
19.199219
32
0.879883
0.799927
1
1
0
no
0.75
0.75
no dnr
5
68
4.799805
71
24
36.39844
240
3.299805
0.5
0.899902
137
7.349609
97
12
null
0
0
no(M2 and SIP pres)
0
1,000
0
66.00098
male
0
4
CHF
COPD/CHF/Cirrhosis
1
12
under $11k
0
12,022
6,259.5586
8,188.11719
8
black
17
4
0.86792
0.780884
4
0
0
no
0.99
0.95
no dnr
4
75
28.796875
96
24
35.39844
77.54688
1.799805
0.699951
4.799805
145
7.449219
322
158
1,430
0
0
no(M2 and SIP pres)
0
1,000
0
56.88397
male
0
7
Lung Cancer
Cancer
1
14
>$50k
9
4,245
3,281.3887
4,371.34766
4
white
39.296875
39
0.107986
0.004
1
0
0
metastatic
0
0
dnr after sadm
2
85
3.599609
135
30
35.59375
112.23438
2.5
0.199982
1.199951
147
7.229492
180
27
1,300
null
0
<2 mo. follow-up
0
24
1
51.55399
female
0
27
COPD
COPD/CHF/Cirrhosis
3
11
under $11k
0
31,701
21,109.5625
25,046.2188
12.5
white
23.699219
36
0.883911
0.806885
1
0
0
no
0.7
0.5
no dnr
27
147
16.199219
153
28
38
93.32812
4.599609
1.299805
1.899902
129
7.5
254
33
1,495
0
null
no(M2 and SIP pres)
0.494751
998
0
77.96594
female
1
11
Coma
Coma
0
12
under $11k
94
53,921
36,673.3438
43,470
31
white
17.796875
20
0.167999
0.112991
21
0
0
no
0.1
0
dnr after sadm
6
67
11.099609
147
38
38.19531
180
2.099609
0.599976
1.399902
134
7.40918
278
28
1,310
null
1
<2 mo. follow-up
1
11
1
41.405
male
0
14
Cirrhosis
COPD/CHF/Cirrhosis
3
12
under $11k
0
11,648
8,647.1719
10,721.7656
5.666664
white
24.097656
18
0.829956
0.721924
1
0
0
no
1
1
no dnr
14
47
18.398438
150
34
39.5
306
1.399902
2.199707
1.5
146
7.379883
373
42
2,545
3
2
no(M2 and SIP pres)
2
998
0
59.41699
male
0
6
CHF
COPD/CHF/Cirrhosis
3
9
under $11k
0
3,689
2,812.7773
2,914.51953
4
hispanic
14.5
13
0.918945
0.862915
1
1
0
no
0.95
0.85
no dnr
6
135
19.898438
111
7
38.39844
340
3.299805
0.899902
0.799927
136
7.449219
138
5
3,625
4
null
SIP>=30
3.183106
997
0
78.76196
female
0
13
Coma
Coma
4
8
under $11k
26
34,205
18,992.0469
23,174.4688
21
white
23.597656
41
0.362976
0.28894
8
1
0
no
0.6
0.5
no dnr
13
60
12.5
124
32
38.69531
245.6875
null
null
0.899902
137
7.429688
164
20
1,800
null
0
adl>=4 (>=5 if sur)
0
164
1
70.04199
female
0
17
MOSF w/Malig
ARF/MOSF
4
8
under $11k
0
30,676
21,929.1094
27,445.9844
17
white
35.5
53
0.201996
0.108994
11
0
0
metastatic
0.1
0
dnr before sadm
-9
77
9.798828
70
12
36.19531
404.75
4
0.5
1.799805
140
7.549805
83
22
900
1
0
adl>=4 (>=5 if sur)
0
92
1
57.366
female
0
10
Lung Cancer
Cancer
1
11
$11-$25k
0
10,310
7,487.3047
9,577.3125
11
black
8.699219
5
0.848999
0.667969
1
0
0
metastatic
0.8
0.5
no dnr
10
143
26.398438
118
30
37
278
2.399902
1.199951
1.899902
154
7.429688
256
47
3,655
0
null
null
0.494751
156
1
70.69098
male
1
24
MOSF w/Malig
ARF/MOSF
2
12
null
0
29,236
20,551.6562
27,707.2812
26
white
29.898438
35
0.404968
0.28595
4
0
0
metastatic
0.5
0.2
dnr after sadm
6
71
5
108
20
37.5
null
2.699707
2.399902
1.299805
132
null
134
35
null
null
0
<2 mo. follow-up
0
24
1
70.17395
female
0
4
CHF
COPD/CHF/Cirrhosis
5
12
under $11k
0
3,382
2,383.6094
2,952.89844
5
white
15.398438
33
0.890991
0.817993
1
1
0
no
0.8
0.8
no dnr
4
67
2.699707
100
28
36.59375
371.375
null
0.899902
2
147
7.489258
254
78
2,375
0
null
no(M2 and SIP pres)
0.494751
996
0
37.71899
male
0
4
Cirrhosis
COPD/CHF/Cirrhosis
3
12
under $11k
0
4,348
2,924.3496
3,215.39844
7
black
16.898438
22
0.910889
0.848999
1
0
0
no
0.95
0.85
no dnr
4
114
5.599609
79
20
36.5
null
2.599609
5.099609
1
133
null
112
7
null
0
1
no(M2 and SIP pres)
1
994
0
29.33099
female
1
36
MOSF w/Malig
ARF/MOSF
2
15
under $11k
0
94,641
60,107.875
70,521.5
49.75
white
30.296875
50
0.567993
0.45697
3
0
0
yes
0.5
0.5
no dnr
36
64
11.099609
110
28
36.69531
209.5
4.099609
0.599976
1.099854
142
7.389648
176
22
1,500
null
2
<2 mo. follow-up
2
36
1
63.10199
male
1
24
ARF/MOSF w/Sepsis
ARF/MOSF
0
12
$25-$50k
0
101,785
null
null
54.666657
hispanic
30.296875
56
0.66394
0.566895
4
0
0
no
0.5
0.5
dnr after sadm
18
107
11.099609
107
28
35.39844
null
3.299805
0.299988
1.199951
147
null
161
7
1,200
null
0
<2 mo. follow-up
0
24
1
47.97299
male
1
3
ARF/MOSF w/Sepsis
ARF/MOSF
0
16
null
41
34,317
21,957.0469
26,373.5469
50
white
54.796875
95
0.014
0.003
6
0
0
no
0
0
dnr after sadm
3
68
11.099609
77
22
36
null
4.099609
1
1.199951
122
null
1,051
22
1,450
null
0
<2 mo. follow-up
0
3
1
63.10199
male
1
8
CHF
COPD/CHF/Cirrhosis
5
null
null
94
45,091
24,652.875
29,997.6562
63
white
33.09375
62
0.161987
0.042
3
1
0
no
0.05
0
no dnr
8
97
4.299805
50
16
35.79688
238.09375
3.099609
0.299988
2.5
146
7.289062
64
71
1,535
null
0
<2 mo. follow-up
0
8
1
67.64697
female
0
22
ARF/MOSF w/Sepsis
ARF/MOSF
3
null
under $11k
0
39,043
25,974.0781
28,633.7188
40
white
30.597656
44
0.549927
0.435974
5
1
0
yes
0.8
0.7
no dnr
22
100
11.099609
151
11
39
80
2
0.5
0.599976
147
7.40918
77
7
2,000
null
1
null
1
234
1
91.69598
male
0
15
COPD
COPD/CHF/Cirrhosis
1
1
under $11k
26
29,155
19,497.1406
23,714.0781
12.333328
black
21.097656
19
0.447998
0.246979
15
0
0
no
0.7
0.5
dnr after sadm
1
61
24.398438
99
10
38.29688
148.3125
2.099609
40.09375
0.899902
158
7.419922
135
54
433
null
2
adl>=4 (>=5 if sur)
2
989
0
68.24597
male
1
18
MOSF w/Malig
ARF/MOSF
2
12
$11-$25k
0
23,307
16,309.6172
22,747.5625
16.333328
white
30.699219
48
0.532959
0.418945
1
0
0
yes
null
null
dnr after sadm
7
63
30.097656
118
22
37.29688
310
1.199951
0.5
0.5
127
7.429688
115
8
1,980
0
3
<2 mo. follow-up
3
18
1
43.754
female
1
4
Lung Cancer
Cancer
1
2
under $11k
0
3,065
2,168.3652
2,810.16992
14
black
47.796875
67
0.031998
0
1
0
0
metastatic
0
0
dnr after sadm
3
47
15.099609
150
30
36.59375
177.53125
2.899902
2.799805
1.299805
154
7.369141
192
36
1,670
7
5
<2 mo. follow-up
5
4
1
54.08398
female
1
23
Coma
Coma
0
18
$25-$50k
9
43,798
28,933.9219
34,577.9688
29.666656
white
17.199219
25
0.834961
0.80188
1
0
0
no
0.6
0.5
dnr after sadm
12
76
8.298828
70
20
35.89844
null
3.699707
0.399963
1.099854
139
null
98
11
3,850
null
0
<2 mo. follow-up
0
23
1
74.02899
female
1
16
ARF/MOSF w/Sepsis
ARF/MOSF
3
12
$11-$25k
44
45,086
28,275.7812
32,509.125
42
white
29.398438
62
0.474976
0.356995
1
1
0
no
0.8
0.5
no dnr
16
59
18.097656
77
28
36.09375
null
3.899902
0.599976
0.699951
141
null
115
4
590
null
0
<2 mo. follow-up
0
16
1
52.93399
male
0
7
COPD
COPD/CHF/Cirrhosis
5
12
under $11k
0
7,492
5,008.3906
5,883.04688
8.5
white
31.296875
36
0.786987
0.657959
1
1
0
no
0.8
0.75
no dnr
7
61
18.398438
124
9
36.69531
133.3125
3
1.899902
8.898438
154
7.479492
165
111
744
0
3
no(M2 and SIP pres)
3
986
0
69.74896
female
0
13
COPD
COPD/CHF/Cirrhosis
2
11
under $11k
0
17,451
11,142.8672
12,898.125
21
white
24
23
0.787964
0.659912
1
0
0
no
0.5
0.3
dnr after sadm
2
120
27.699219
106
40
38.09375
null
3.299805
1.199951
10.298828
135
7.389648
254
83
0
6
5
adl>=4 (>=5 if sur)
5
988
0
78.17896
female
1
46
ARF/MOSF w/Sepsis
ARF/MOSF
5
12
null
9
118,516
75,014.6875
86,490
53.25
white
44.5
89
0.188995
0.099991
1
1
0
no
0.2
0.05
dnr after sadm
16
45
18.296875
100
20
37.59375
300
null
null
0.899902
138
7.399414
100
15
1,355
null
7
<2 mo. follow-up
7
46
1
45.862
male
0
25
ARF/MOSF w/Sepsis
ARF/MOSF
2
12
null
0
64,846
42,125.4688
48,898.6875
36.5
white
30.597656
40
0.73999
0.658936
4
0
0
no
0.5
0.5
no dnr
25
60
4.399414
113
14
36.69531
88.875
1.899902
0.399963
0.599976
135
7.459961
388
10
5,840
null
null
null
2.752441
985
0
68.77795
male
0
18
Cirrhosis
COPD/CHF/Cirrhosis
4
11
under $11k
9
16,177
11,637.75
12,156.0078
12.666664
white
18.898438
26
0.728882
0.575928
1
0
0
no
0.05
0.02
dnr after sadm
2
64
6.299805
120
42
39.09375
257.125
2.699707
0.899902
0.299988
132
7.55957
135
2
2,415
null
5
<2 mo. follow-up
5
34
1
49.41498
male
1
146
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
under $11k
26
380,612
250,155
307,091.75
51.25
white
31.699219
65
0.572998
0.461975
8
0
0
no
0.7
0.9
dnr after sadm
145
116
10.099609
74
12
40
330
3
0.699951
1.099854
131
7.479492
117
13
2,240
null
2
adl>=4 (>=5 if sur)
2
146
1
33.19897
male
0
8
ARF/MOSF w/Sepsis
ARF/MOSF
4
11
$11-$25k
0
12,548
8,606.9453
10,165.5156
16.5
hispanic
26.296875
52
0.869995
0.823975
1
1
0
no
0.5
0.5
no dnr
8
128
19
116
40
37.69531
206.65625
2.599609
0.699951
0.599976
142
7.439453
192
22
2,370
0
4
SIP>=30
4
984
0
61.314
female
0
5
Lung Cancer
Cancer
3
9
null
0
4,206
3,020.4023
3,990.21875
8
white
26.398438
18
0.487976
0.168976
1
0
0
metastatic
0.3
0
dnr after sadm
2
109
9.099609
78
24
37.09375
216
3.699707
0.5
0.899902
141
7.369141
146
30
null
0
null
<2 mo. follow-up
0.494751
47
1
53.71399
female
0
7
Lung Cancer
Cancer
3
7
under $11k
0
6,541
4,582.8438
5,900.66797
3.5
white
28.796875
18
0.444946
0.134979
1
0
0
metastatic
0.2
0
dnr after sadm
1
68
22.199219
65
12
35.59375
158
3.599609
0.5
3.899902
136
7.329102
210
148
1,325
3
5
SIP>=30
5
80
1
57.383
female
1
11
ARF/MOSF w/Sepsis
ARF/MOSF
1
9
null
41
80,893
51,551.375
61,187.25
40.5
white
29.296875
46
0.514893
0.398987
8
0
0
no
0.1
0.05
dnr after sadm
9
63
null
60
24
36
292.5625
3.799805
0.799927
1.299805
142
7.429688
103
29
null
null
4
<2 mo. follow-up
4
11
1
66.88599
female
0
7
ARF/MOSF w/Sepsis
ARF/MOSF
1
14
$25-$50k
41
11,154
7,366.8008
9,033.42969
21.5
white
14.599609
19
0.830933
0.772949
1
1
0
no
1
0.95
no dnr
7
64
6.099609
75
9
37.79688
280
3.199707
1.099854
1.399902
137
7.489258
168
30
1,698
null
0
null
0
982
0
78.00098
male
0
10
COPD
COPD/CHF/Cirrhosis
2
11
under $11k
0
15,832
9,529.125
11,788.2578
13.5
white
15.099609
32
0.85791
0.765991
1
0
0
no
0.9
0.95
no dnr
10
69
13
126
28
37.79688
151
2.199707
0.5
0.899902
146
7.489258
95
13
1,315
1
1
null
1
248
1
79.02295
male
0
24
MOSF w/Malig
ARF/MOSF
4
12
$11-$25k
0
35,428
24,418.9062
30,912.5781
32.333313
white
37.5
52
0.227997
0.127991
7
0
0
yes
0.15
0
dnr before sadm
-5
63
9.398438
116
10
38.19531
125
3.699707
1
0.699951
147
7.419922
147
20
760
null
5
<2 mo. follow-up
5
26
1
40.961
female
0
43
ARF/MOSF w/Sepsis
ARF/MOSF
2
10
null
0
93,065
60,890.4062
72,025.5625
41.5
white
29.898438
56
0.804932
0.73999
1
0
0
no
0.6
0.6
no dnr
43
131
8.898438
77
22
36.29688
163.25
2.899902
0.399963
5.399414
135
7.359375
374
82
2,250
null
0
no(M2 and SIP pres)
0
978
0
55.96198
female
0
5
CHF
COPD/CHF/Cirrhosis
3
7
null
0
3,799
2,804.1816
2,853.17969
10
white
19.199219
25
0.891968
0.819946
1
1
0
no
0.8
0.7
no dnr
5
120
0.799927
119
40
35.39844
null
null
null
1.5
142
null
314
23
605
0
3
no(M2 and SIP pres)
3
386
1